Tegria Names TriZetto CEO Craig Mengert to Lead Post-Acquisition Growth
Tegria, a healthcare consulting firm, has appointed Craig Mengert as CEO, effective immediately. The move follows the company's acquisition by Altaris, a private equity firm focused on healthcare investments. Mengert, who will also join the board, replaces retiring CEO Brian Cahill after a 47-year tenure.
Mengert spent three decades in healthcare, most recently leading TriZetto, a Cognizant subsidiary. He inherited a declining business and grew it to consistent double-digit organic growth above 14% annually while managing a $1 billion P&L with operating margins exceeding 44%.
AI Integration as a Core Strategy
At TriZetto, Mengert championed the integration of artificial intelligence across all platforms. He developed the TriZetto Assistant, an embedded tool designed to automate administrative workflows in healthcare settings.
His approach prioritizes what he calls "governance before autonomy"-deploying AI responsibly in a regulated industry. This philosophy addresses a central concern for healthcare executives: how to implement powerful tools without creating compliance or security risks.
Mengert's earlier experience at Horizon BlueCross BlueShield of New Jersey gives him insight into both the payer and provider sides of healthcare operations. For a consulting firm serving both segments, this dual perspective matters operationally.
The Altaris Advantage
The timing of Mengert's appointment reflects Altaris's strategic role. The private equity firm doesn't function as a passive investor but typically takes controlling stakes in companies positioned to reduce healthcare costs and improve outcomes.
Altaris's capital infusion enables Tegria to invest heavily in research, pursue acquisitions, and scale AI-driven solutions globally. Tegria currently employs over 1,000 professionals and serves 650 clients.
This positions the firm to compete more directly with larger generalist consultants while carving out a niche in practical, measurable AI implementation for healthcare operations.
The Transition
Cahill transitions to independent director on Tegria's board, preserving institutional knowledge and strategic continuity. His previous role leading Cumberland Consulting Group before its acquisition by Tegria gives him deep knowledge of the client base.
The structure balances Cahill's oversight with Mengert's focus on technology-driven growth.
The Market Opportunity
Healthcare providers and payers face pressure to modernize legacy systems, reduce operational costs, and meet consumer expectations for digital experiences. Administrative tasks-claims processing, prior authorizations-consume resources and contribute to clinician burnout.
Mengert's strategy will likely focus on using AI to automate repetitive work, deploy predictive analytics for at-risk patient identification, and generate data-driven insights for clinical and financial decisions. The goal is shifting clinicians from data-entry roles to data validation, freeing time for patient care.
Success depends on demonstrating measurable return on investment and improved experience for both patients and providers-not on technology for its own sake.
For executives evaluating healthcare consulting partnerships or AI implementation strategies, AI for Healthcare and AI for Executives & Strategy resources can help clarify how responsible AI deployment differs from hype.
Your membership also unlocks:
